Celgene Stock Quote
$99.37 $0.42 0.4%
BATS BZX Real Time Price as of September 20, 2019, 1:44 p.m. EDT View Interactive CELG Charts

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

News & Analysis: Celgene

The Fool has written over 900 articles on Celgene.


Market Moves



What Happened in the Stock Market Today

Bristol-Myers Squibb and Celgene made a deal to sell a blockbuster drug to Amgen, and Disney and Target are forming a retail collaboration.

How Big Is Celgene's Latest Good News?

FDA approval of fedratinib could lead to significantly more revenue for the biotech. But even better news could be on the way.

Interactive Chart